Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 May 2023 | Story Leonie Bolleurs | Photo Supplied
Spineless Cactus
Axel Tarrisse (far left), a PhD student in the Department of Sustainable Food Systems, working on the biogas and fodder potential of spineless cactus in Africa. Pictured with him are Prof Maryna de Wit, his supervisor and Associate Professor in the UFS Department of Sustainable Food Systems and Development, and Dr Herman Fouché from the Agricultural Research Council.

The spineless cactus is a unique perennial plant that is able to yield close to 40 tons of dry matter per hectare per year with a rainfall of 500 mm per annum. “This equates eight tons of biomethane or 11 000 litres of diesel-equivalent energy per hectare,” says Axel Tarrisse, a PhD student in the Department of Sustainable Food Systems and Development at the University of the Free State (UFS), who is working on the biogas and fodder potential of spineless cactus in Africa.

Tarrisse believes biogas, produced from the spineless cactus, has the potential to complement the supply of South Africa’s existing industrial energy companies to produce sustainable jet fuel and diesel and a variety of other products with the gas-to-liquid process they use.

Developing biogas

He says with rainfall, key nutrients, carbon dioxide, and solar energy it is possible to produce biomass from cactus.

“First, we harvest the cactus and macerate it prior to going into an anaerobic digester where it is heated to 38°C, the same as a cow’s body temperature. Inside the digester, naturally occurring bacteria, similar to those found in their stomachs, break down the cactus, resulting in the production of biogas. This biogas is composed of both methane and carbon dioxide,” he explains.

According to him, biogas generated through this process can be used in a number of ways. This includes running generators to produce electricity or burning it to generate heat. It will also serve as a feedstock to replace coal and natural gas used by companies such as PetroSA and Sasol in their production of synthetic renewable fuels.

“The methane can also be separated from the carbon dioxide and compressed into bottles, creating compressed biomethane. This can be used as a replacement for liquid petroleum gas (LPG), as well as petrol and diesel in vehicles, such as bakkies, tractors, buses, and delivery trucks.”

The carbon dioxide produced in the process can, for example, be used to replace the fossil-based carbon dioxide typically used in the production of carbonated beverages. Additionally, it can be applied to extend the shelf life of packaged foods, serve as a water softener, and even be applied to a variety of industrial applications.

Commercialisation 

Biogas/biomethane is already produced in Mexico on a commercial scale. In Northeast Brazil, farmers have planted 600 000 hectares of spineless cactus, also known as Palma Forrageira, but the machinery needed to harvest it only became commercially available this year.

Back home in South Africa, just 30 km outside of Bloemfontein, Barren Energy farm is at Stage 1 with 140 hectares of high-density cactus planted to provide the initial feedstock for anaerobic digestion. With 600 hectares, they will be able to produce five million litres of diesel-equivalent methane.

Tarrisse says, “With the right methodology and management system, producing biogas from the spineless cactus will be adopted relatively quickly on a commercial scale.”

He believes that the lack of investment in cultivating the spineless cactus as a crop for fodder in South Africa may be due to a few factors. “It is easier to stick to what is known, such as irrigating lucerne and maize and managing these crops with existing planters, pest management solutions, and harvesting machinery than to develop local machinery and management solutions for a perfectly adapted crop,” he says. 

Compelling reasons

According to Tarrisse, there are several compelling reasons to consider the spineless cactus as a source of biogas in South Africa.

Firstly, he explains, “Only the cactus pads, harvested from high-density plantations (20 000 plants per hectares), are used for biogas production.”

“Secondly, the spineless cactus can yield large volumes of biomass from marginal semi-arid land where conditions are unsuitable for conventional crop cultivation. This makes it an ideal option for the 65% of South African land that receives less than 500 mm of rainfall annually.”

Thirdly, he says, “The plant contains 30 to 50% of easily digestible sugars, which degrades easily in an anaerobic digester. This simple, low-tech process can provide a substantial amount of baseload energy with relatively limited capital expenditure, which is particularly important in developing countries such as South Africa where capital is difficult to raise.”

“On top of that, anaerobic digestion only extracts carbon, oxygen, and hydrogen molecules from the cactus, while most of the macro- and micronutrients, water, and some fibres remain in the digestate. This nutrient-rich cactus digestate can then be spread on the cactus fields, reducing the need for fertiliser once the plantation has been fertilised in the first two years of implementation.”

Societal impact

Besides the benefits of producing biogas from the cactus plant, there is also the opportunity of job creation. “This farming can create one million direct job opportunities from only 3% of South Africa’s land area, approximately 4 million hectares,” says Tarrisse.

He is of the opinion that if production was at scale, as opposed to the current small orchard-style farming of cactus, there would be substantial biomass available to sustain not only biomethane, but also to support various bio-industries, such as protein production through cactus fermentation, biomaterials as a substitute for wood-based cellulose, organic acids, and bioplastics. “Consequently, cactus provides a climate-resilient, drought-resistant, and perennial feedstock for food, feed, fibre, and fuel in semi-arid Southern Africa,” he says.

Tarrisse states that this initiative also has the potential to significantly reduce migration from rural to urban areas, therefore addressing issues related to the growth of urbanisation, such as the provision of infrastructure and crime.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept